Psychiatry

Latest News


CME Content


We know you're busy. But even doctors find themselves with a little time to kill every now and then. When this happens, we suppose you could do something like read a book or talk with a friend or family member, but who wants to do that?

Special Feature: Q&A

By

We asked our participants for their insights and opinions on the impact of social and emotional impairments associated with ADHD, considerations for the patient, consequences for the payer, and cost implications across the life span. Strattera® (atomoxetine HCl) is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children age 6 and older, adolescents, and adults.

This article provides answers to several common questions associated with the use of Strattera® (atomoxetine HCl) to treat patients with ADHD. Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children age 6 and older, adolescents, and adults.

Bipolar disorders remain under-recognized, misdiagnosed, and mistreated in both psychiatric and primary care settings.

The topic of health information technology (IT) seems to be popping up everywhere nowadays. No longer the province of healthcare and tech-focused websites...

Attention-deficit/hyperactivity disorder (ADHD) is the most common neuropsychiatric disorder afflicting children and adolescents in the United States. Epidemiologic studies in the United States indicate that approximately 5% of youths have ADHD.1 ADHD is characterized by the childhood onset of symptoms of inattention, distractibility, impulsivity, and motor hyperactivity that occur in more than one domain of functioning (eg, home, work, school, socially).

The End of Psychotherapy?

By

There is a small, yet important, downward trend in the number of office-based psychiatrists providing psychotherapy to their patients, according to a new report published in the Archives of General Psychiatry.